1. Home
  2. SCPH vs RMR Comparison

SCPH vs RMR Comparison

Compare SCPH & RMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • RMR
  • Stock Information
  • Founded
  • SCPH 2013
  • RMR 1986
  • Country
  • SCPH United States
  • RMR United States
  • Employees
  • SCPH N/A
  • RMR N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • RMR Professional Services
  • Sector
  • SCPH Health Care
  • RMR Consumer Discretionary
  • Exchange
  • SCPH Nasdaq
  • RMR Nasdaq
  • Market Cap
  • SCPH 299.0M
  • RMR 290.8M
  • IPO Year
  • SCPH 2017
  • RMR N/A
  • Fundamental
  • Price
  • SCPH $5.62
  • RMR $17.28
  • Analyst Decision
  • SCPH Buy
  • RMR
  • Analyst Count
  • SCPH 3
  • RMR 0
  • Target Price
  • SCPH $12.00
  • RMR N/A
  • AVG Volume (30 Days)
  • SCPH 2.4M
  • RMR 62.2K
  • Earning Date
  • SCPH 11-12-2025
  • RMR 11-10-2025
  • Dividend Yield
  • SCPH N/A
  • RMR 10.46%
  • EPS Growth
  • SCPH N/A
  • RMR N/A
  • EPS
  • SCPH N/A
  • RMR 1.12
  • Revenue
  • SCPH $49,969,000.00
  • RMR $194,993,000.00
  • Revenue This Year
  • SCPH $108.95
  • RMR $323.25
  • Revenue Next Year
  • SCPH $78.30
  • RMR $1.07
  • P/E Ratio
  • SCPH N/A
  • RMR $15.32
  • Revenue Growth
  • SCPH 107.79
  • RMR 1.73
  • 52 Week Low
  • SCPH $1.94
  • RMR $13.48
  • 52 Week High
  • SCPH $6.28
  • RMR $26.06
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 52.96
  • RMR 58.60
  • Support Level
  • SCPH N/A
  • RMR $16.64
  • Resistance Level
  • SCPH $5.62
  • RMR $17.10
  • Average True Range (ATR)
  • SCPH 0.04
  • RMR 0.29
  • MACD
  • SCPH -0.21
  • RMR 0.05
  • Stochastic Oscillator
  • SCPH 99.56
  • RMR 94.19

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.

About RMR The RMR Group Inc.

The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.

Share on Social Networks: